XML 35 R28.htm IDEA: XBRL DOCUMENT
v3.2.0.727

Investments and Derivative Instruments Level 3 (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2015
Investments [Abstract] |
Net Realized Capital Gains (Losses) | Net Realized Capital Gains (Losses)
| Three Months Ended June 30, |  | Six Months Ended June 30,
(Before tax) | 2015 | 2014 |  | 2015 | 2014
Gross gains on sales | $ | 121 |  | $ | 122 |  |  | $ | 318 |  | $ | 305 |
Gross losses on sales | (112 | ) | (33 | ) |  | (260 | ) | (162 | )
Net OTTI losses recognized in earnings | (11 | ) | (7 | ) |  | (23 | ) | (29 | )
Valuation allowances on mortgage loans | — |  | (3 | ) |  | (3 | ) | (3 | )
Periodic net coupon settlements on credit derivatives | 4 |  | 2 |  |  | 5 |  | 1 |
Results of variable annuity hedge program |  |  |  |  |  |
GMWB derivatives, net | (4 | ) | (6 | ) |  | (3 | ) | 9 |
Macro hedge program | (23 | ) | (15 | ) |  | (27 | ) | (25 | )
Total results of variable annuity hedge program | (27 | ) | (21 | ) |  | (30 | ) | (16 | )
Other, net [1] | 34 |  | (64 | ) |  | 7 |  | (135 | )
Net realized capital gains (losses) | $ | 9 |  | $ | (4 | ) |  | $ | 14 |  | $ | (39 | )
[1] | Primarily consists of changes in the value of non-qualifying derivatives, transactional foreign currency revaluation gains (losses) on yen denominated fixed payout annuity liabilities and gains (losses) on non-qualifying derivatives used to hedge the foreign currency exposure of the liabilities. For the three months ended June 30, 2015 and 2014, gains (losses) from transactional foreign currency revaluation of the yen denominated fixed payout annuity liabilities were $16 and $(18), respectively. For the six months ended June 30, 2015 and 2014, gains (losses) from transactional foreign currency revaluation of the yen denominated fixed payout annuity liabilities were $16 and $(46), respectively. For the three months ended June 30, 2015 and 2014, gains (losses) on instruments used to hedge the foreign currency exposure on the fixed payout annuities were $(17) and $13, respectively. For the six months ended June 30, 2015 and 2014, gains (losses) on instruments used to hedge the foreign currency exposure on the fixed payout annuities were $(31) and $28, respectively.
Net realized capital gains and losses from investment sales are reported as a component of revenues and are determined on a specific identification basis. Before tax, net gains and losses on sales and impairments previously reported as unrealized gains in AOCI were $6 and $43, respectively, for the three and six months ended June 30, 2015, and $82 and $125 for the three and six months ended June 30, 2014, respectively. Proceeds from sales of AFS securities totaled $5.6 billion and $11.8 billion, respectively, for three and six months ended June 30, 2015, and $5.8 billion and $14.3 billion for the three and six months ended June 30, 2014, respectively.
Other-Than-Temporary Impairment Losses | Recognition and Presentation of Other-Than-Temporary Impairments The Company deems bonds and certain equity securities with debt-like characteristics (collectively “debt securities”) to be other-than-temporarily impaired (“impaired”) if a security meets the following conditions: a) the Company intends to sell or it is more likely than not that the Company will be required to sell the security before a recovery in value, or b) the Company does not expect to recover the entire amortized cost basis of the security. If the Company intends to sell or it is more likely than not that the Company will be required to sell the security before a recovery in value, a charge is recorded in net realized capital losses equal to the difference between the fair value and amortized cost basis of the security. For those impaired debt securities which do not meet the first condition and for which the Company does not expect to recover the entire amortized cost basis, the difference between the security’s amortized cost basis and the fair value is separated into the portion representing a credit OTTI, which is recorded in net realized capital losses, and the remaining non-credit impairment, which is recorded in OCI. Generally, the Company determines a security’s credit impairment as the difference between its amortized cost basis and its best estimate of expected future cash flows discounted at the security’s effective yield prior to impairment. The remaining non-credit impairment is the difference between the security’s fair value and the Company’s best estimate of expected future cash flows discounted at the security’s effective yield prior to the impairment, which typically represents current market liquidity and risk premiums. The previous amortized cost basis less the impairment recognized in net realized capital losses becomes the security’s new cost basis. The Company accretes the new cost basis to the estimated future cash flows over the expected remaining life of the security by prospectively adjusting the security’s yield, if necessary. The Company’s evaluation of whether a credit impairment exists for debt securities includes but is not limited to, the following factors: (a) changes in the financial condition of the security’s underlying collateral, (b) whether the issuer is current on contractually obligated interest and principal payments, (c) changes in the financial condition, credit rating and near-term prospects of the issuer, (d) the extent to which the fair value has been less than the amortized cost of the security and (e) the payment structure of the security. The Company’s best estimate of expected future cash flows used to determine the credit loss amount is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the security. The Company’s best estimate of future cash flows involves assumptions including, but not limited to, various performance indicators, such as historical and projected default and recovery rates, credit ratings, current and projected delinquency rates, and loan-to-value ("LTV") ratios. In addition, for structured securities, the Company considers factors including, but not limited to, average cumulative collateral loss rates that vary by vintage year, commercial and residential property value declines that vary by property type and location and commercial real estate delinquency levels. These assumptions require the use of significant management judgment and include the probability of issuer default and estimates regarding timing and amount of expected recoveries which may include estimating the underlying collateral value. In addition, projections of expected future debt security cash flows may change based upon new information regarding the performance of the issuer and/or underlying collateral such as changes in the projections of the underlying property value estimates. For equity securities where the decline in the fair value is deemed to be other-than-temporary, a charge is recorded in net realized capital losses equal to the difference between the fair value and cost basis of the security. The previous cost basis less the impairment becomes the security’s new cost basis. The Company asserts its intent and ability to retain those equity securities deemed to be temporarily impaired until the price recovers. Once identified, these securities are systematically restricted from trading unless approved by investment and accounting professionals. The investment and accounting professionals will only authorize the sale of these securities based on predefined criteria that relate to events that could not have been reasonably foreseen. Examples of the criteria include, but are not limited to, the deterioration in the issuer’s financial condition, security price declines, a change in regulatory requirements or a major business combination or major disposition. The primary factors considered in evaluating whether an impairment exists for an equity security include, but are not limited to: (a) the length of time and extent to which the fair value has been less than the cost of the security, (b) changes in the financial condition, credit rating and near-term prospects of the issuer, (c) whether the issuer is current on preferred stock dividends and (d) the intent and ability of the Company to retain the investment for a period of time sufficient to allow for recovery. Impairments for the three and six months ended June 30, 2015 were $11 and $23, respectively, and $7 and $29 for three and six months ended June 30, 2014, respectively. Impairments for the three and six months ended June 30, 2015 primarily consisted of securities in an unrealized loss position which the Company had made the decision to sell. Impairments for the three and six months ended June 30, 2014 primarily consisted of credit impairments caused by issuer specific deterioration. The following table presents a roll-forward of the Company’s cumulative credit impairments on debt securities held.
| Three Months Ended June 30, | Six Months Ended June 30,
(Before tax) | 2015 | 2014 | 2015 | 2014
Balance as of beginning of period | $ | (412 | ) | $ | (531 | ) | $ | (424 | ) | $ | (552 | )
Additions for credit impairments recognized on [1]: |  |  |  |
Securities not previously impaired | — |  | (1 | ) | (3 | ) | (8 | )
Securities previously impaired | (1 | ) | (3 | ) | (1 | ) | (14 | )
Reductions for credit impairments previously recognized on: |  |  |  |
Securities that matured or were sold during the period | 6 |  | 40 |  | 10 |  | 73 |
Securities the Company made the decision to sell or more likely than not will be required to sell | — |  | — |  | 2 |  | — |
Securities due to an increase in expected cash flows | 19 |  | 7 |  | 28 |  | 13 |
Balance as of end of period | $ | (388 | ) | $ | (488 | ) | $ | (388 | ) | $ | (488 | )
[1] | These additions are included in the net OTTI losses recognized in earnings in the Condensed Consolidated Statements of Operations.
Schedule of Available-for-sale Securities Reconciliation [Table Text Block] | Available-for-Sale Securities The following table presents the Company’s AFS securities by type.
| June 30, 2015 |  | December 31, 2014
| Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Non-Credit OTTI [1] |  | Cost or Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Non-Credit OTTI [1]
ABS | $ | 2,891 |  | $ | 30 |  | $ | (31 | ) | $ | 2,890 |  | $ | — |  |  | $ | 2,470 |  | $ | 39 |  | $ | (37 | ) | $ | 2,472 |  | $ | (1 | )
CDOs [2] | 3,130 |  | 106 |  | (15 | ) | 3,218 |  | — |  |  | 2,776 |  | 98 |  | (36 | ) | 2,841 |  | — |
CMBS | 4,533 |  | 159 |  | (28 | ) | 4,664 |  | (6 | ) |  | 4,235 |  | 196 |  | (16 | ) | 4,415 |  | (6 | )
Corporate | 25,167 |  | 1,677 |  | (234 | ) | 26,610 |  | (6 | ) |  | 25,188 |  | 2,382 |  | (211 | ) | 27,359 |  | (3 | )
Foreign govt./govt. agencies | 1,291 |  | 46 |  | (24 | ) | 1,313 |  | — |  |  | 1,592 |  | 73 |  | (29 | ) | 1,636 |  | — |
Municipal | 11,445 |  | 887 |  | (34 | ) | 12,298 |  | — |  |  | 11,735 |  | 1,141 |  | (5 | ) | 12,871 |  | — |
RMBS | 3,891 |  | 98 |  | (20 | ) | 3,969 |  | — |  |  | 3,815 |  | 122 |  | (19 | ) | 3,918 |  | (1 | )
U.S. Treasuries | 3,991 |  | 195 |  | (20 | ) | 4,166 |  | — |  |  | 3,551 |  | 326 |  | (5 | ) | 3,872 |  | — |
Total fixed maturities, AFS | 56,339 |  | 3,198 |  | (406 | ) | 59,128 |  | (12 | ) |  | 55,362 |  | 4,377 |  | (358 | ) | 59,384 |  | (11 | )
Equity securities, AFS [3] | 825 |  | 56 |  | (25 | ) | 856 |  | — |  |  | 676 |  | 50 |  | (27 | ) | 699 |  | — |
Total AFS securities | $ | 57,164 |  | $ | 3,254 |  | $ | (431 | ) | $ | 59,984 |  | $ | (12 | ) |  | $ | 56,038 |  | $ | 4,427 |  | $ | (385 | ) | $ | 60,083 |  | $ | (11 | )
[1] | Represents the amount of cumulative non-credit OTTI losses recognized in OCI on securities that also had credit impairments. These losses are included in gross unrealized losses as of June 30, 2015 and December 31, 2014.
[2] | Gross unrealized gains (losses) exclude the fair value of bifurcated, embedded derivative features of certain securities. Subsequent changes in value are recorded in net realized capital gains (losses).
[3] | Excludes equity securities, FVO, with a cost and fair value of $351 and $348, respectively, as of December 31, 2014. The Company did not hold any equity securities, FVO as of June 30, 2015.
Investments Classified by Contractual Maturity Date [Table Text Block] | The following table presents the Company’s fixed maturities, AFS, by contractual maturity year.
| June 30, 2015 | December 31, 2014
Contractual Maturity | Amortized Cost | Fair Value | Amortized Cost | Fair Value
One year or less | $ | 1,946 |  | $ | 1,971 |  | $ | 2,141 |  | $ | 2,168 |
Over one year through five years | 11,455 |  | 11,931 |  | 11,264 |  | 11,827 |
Over five years through ten years | 8,839 |  | 9,119 |  | 8,802 |  | 9,226 |
Over ten years | 19,654 |  | 21,366 |  | 19,859 |  | 22,517 |
Subtotal | 41,894 |  | 44,387 |  | 42,066 |  | 45,738 |
Mortgage-backed and asset-backed securities | 14,445 |  | 14,741 |  | 13,296 |  | 13,646 |
Total fixed maturities, AFS | $ | 56,339 |  | $ | 59,128 |  | $ | 55,362 |  | $ | 59,384 |
Estimated maturities may differ from contractual maturities due to security call or prepayment provisions. Due to the potential for variability in payment speeds (i.e. prepayments or extensions), mortgage-backed and asset-backed securities are not categorized by contractual maturity.
Unrealized Loss Aging on AFS Securities [Table Text Block] | Unrealized Losses on AFS Securities The following tables present the Company’s unrealized loss aging for AFS securities by type and length of time the security was in a continuous unrealized loss position.
| June 30, 2015
| Less Than 12 Months |  | 12 Months or More |  | Total
| Amortized Cost | Fair Value | Unrealized Losses |  | Amortized Cost | Fair Value | Unrealized Losses |  | Amortized Cost | Fair Value | Unrealized Losses
ABS | $ | 836 |  | $ | 834 |  | $ | (2 | ) |  | $ | 396 |  | $ | 367 |  | $ | (29 | ) |  | $ | 1,232 |  | $ | 1,201 |  | $ | (31 | )
CDOs [1] | 928 |  | 925 |  | (3 | ) |  | 1,232 |  | 1,217 |  | (12 | ) |  | 2,160 |  | 2,142 |  | (15 | )
CMBS | 930 |  | 912 |  | (18 | ) |  | 194 |  | 184 |  | (10 | ) |  | 1,124 |  | 1,096 |  | (28 | )
Corporate | 6,266 |  | 6,084 |  | (182 | ) |  | 575 |  | 523 |  | (52 | ) |  | 6,841 |  | 6,607 |  | (234 | )
Foreign govt./govt. agencies | 460 |  | 445 |  | (15 | ) |  | 109 |  | 100 |  | (9 | ) |  | 569 |  | 545 |  | (24 | )
Municipal | 1,159 |  | 1,128 |  | (31 | ) |  | 35 |  | 32 |  | (3 | ) |  | 1,194 |  | 1,160 |  | (34 | )
RMBS | 1,064 |  | 1,057 |  | (7 | ) |  | 310 |  | 297 |  | (13 | ) |  | 1,374 |  | 1,354 |  | (20 | )
U.S. Treasuries | 846 |  | 827 |  | (19 | ) |  | 62 |  | 61 |  | (1 | ) |  | 908 |  | 888 |  | (20 | )
Total fixed maturities, AFS | 12,489 |  | 12,212 |  | (277 | ) |  | 2,913 |  | 2,781 |  | (129 | ) |  | 15,402 |  | 14,993 |  | (406 | )
Equity securities, AFS [2] | 364 |  | 346 |  | (18 | ) |  | 67 |  | 60 |  | (7 | ) |  | 431 |  | 406 |  | (25 | )
Total securities in an unrealized loss position | $ | 12,853 |  | $ | 12,558 |  | $ | (295 | ) |  | $ | 2,980 |  | $ | 2,841 |  | $ | (136 | ) |  | $ | 15,833 |  | $ | 15,399 |  | $ | (431 | )
| December 31, 2014
| Less Than 12 Months |  | 12 Months or More |  | Total
| Amortized Cost | Fair Value | Unrealized Losses |  | Amortized Cost | Fair Value | Unrealized Losses |  | Amortized Cost | Fair Value | Unrealized Losses
ABS | $ | 897 |  | $ | 893 |  | $ | (4 | ) |  | $ | 473 |  | $ | 440 |  | $ | (33 | ) |  | $ | 1,370 |  | $ | 1,333 |  | $ | (37 | )
CDOs [1] | 748 |  | 743 |  | (5 | ) |  | 1,489 |  | 1,461 |  | (31 | ) |  | 2,237 |  | 2,204 |  | (36 | )
CMBS | 230 |  | 227 |  | (3 | ) |  | 319 |  | 306 |  | (13 | ) |  | 549 |  | 533 |  | (16 | )
Corporate | 3,082 |  | 2,980 |  | (102 | ) |  | 1,177 |  | 1,068 |  | (109 | ) |  | 4,259 |  | 4,048 |  | (211 | )
Foreign govt./govt. agencies | 363 |  | 349 |  | (14 | ) |  | 227 |  | 212 |  | (15 | ) |  | 590 |  | 561 |  | (29 | )
Municipal | 74 |  | 73 |  | (1 | ) |  | 86 |  | 82 |  | (4 | ) |  | 160 |  | 155 |  | (5 | )
RMBS | 320 |  | 318 |  | (2 | ) |  | 433 |  | 416 |  | (17 | ) |  | 753 |  | 734 |  | (19 | )
U.S. Treasuries | 432 |  | 431 |  | (1 | ) |  | 361 |  | 357 |  | (4 | ) |  | 793 |  | 788 |  | (5 | )
Total fixed maturities, AFS | 6,146 |  | 6,014 |  | (132 | ) |  | 4,565 |  | 4,342 |  | (226 | ) |  | 10,711 |  | 10,356 |  | (358 | )
Equity securities, AFS [2] | 172 |  | 160 |  | (12 | ) |  | 102 |  | 87 |  | (15 | ) |  | 274 |  | 247 |  | (27 | )
Total securities in an unrealized loss position | $ | 6,318 |  | $ | 6,174 |  | $ | (144 | ) |  | $ | 4,667 |  | $ | 4,429 |  | $ | (241 | ) |  | $ | 10,985 |  | $ | 10,603 |  | $ | (385 | )
[1] | Unrealized losses exclude the change in fair value of bifurcated embedded derivative features of certain securities, for which changes in fair value are recorded in net realized capital gains (losses).
[2] | As of June 30, 2015 and December 31, 2014, excludes equity securities, FVO which are included in equity securities, AFS on the Condensed Consolidated Balance Sheets.
As of June 30, 2015, AFS securities in an unrealized loss position, consisted of 3,957 securities, primarily in the corporate sector, which are depressed primarily due to an increase in interest rates and/or wider credit spreads since the securities were purchased. As of June 30, 2015, 93% of these securities were depressed less than 20% of cost or amortized cost. The increase in unrealized losses as compared to December 31, 2014, was primarily attributable to an increase in interest rates.
Schedule of Variable Interest Entities [Table Text Block] | Consolidated VIEs The following table presents the carrying value of assets and liabilities, and the maximum exposure to loss relating to the VIEs for which the Company is the primary beneficiary. Creditors have no recourse against the Company in the event of default by these VIEs nor does the Company have any implied or unfunded commitments to these VIEs. The Company’s financial or other support provided to these VIEs is limited to its collateral or investment management services and original investment.
| June 30, 2015 |  | December 31, 2014
| Total Assets | Total Liabilities [1] | Maximum Exposure to Loss [2] |  | Total Assets | Total Liabilities [1] | Maximum Exposure to Loss [2]
CDOs [3] | $ | 5 |  | $ | 5 |  | $ | — |  |  | $ | 5 |  | $ | 5 |  | $ | — |
Investment funds [4] | 203 |  | — |  | 205 |  |  | 238 |  | — |  | 243 |
Limited partnerships and other alternative investments | 2 |  | — |  | 2 |  |  | 3 |  | 1 |  | 2 |
Total | $ | 210 |  | $ | 5 |  | $ | 207 |  |  | $ | 246 |  | $ | 6 |  | $ | 245 |
[1] | Included in other liabilities in the Company’s Condensed Consolidated Balance Sheets.
[2] | The maximum exposure to loss represents the maximum loss amount that the Company could recognize as a reduction in net investment income or as a realized capital loss and is the cost basis of the Company’s investment.
[3] | Total assets included in cash in the Company’s Condensed Consolidated Balance Sheets.
[4] | Total assets included in fixed maturities, FVO, short-term investments, equity, AFS, and cash in the Company’s Condensed Consolidated Balance Sheets.
CDOs represent structured investment vehicles for which the Company has a controlling financial interest as it provides collateral management services, earns a fee for those services and also holds investments in the securities issued by these vehicles. Investment funds represent wholly-owned fixed income funds for which the Company has management and control of the investments which is the activity that most significantly impacts its economic performance. Limited partnerships represent one hedge fund of funds for which the Company holds a majority interest in the fund as an investment.
Non-qualifying Strategies for Hedge Accounting [Abstract] |
Notional and Fair Value for Macro Hedge Program [Table Text Block] | Macro Hedge Program The Company utilizes equity options, swaps, futures, and foreign currency options to partially hedge against a decline in the equity markets and the resulting statutory surplus and capital impact primarily arising from the guaranteed minimum death benefit ("GMDB") and GMWB obligations. The following table presents notional and fair value for the macro hedge program.
| Notional Amount |  | Fair Value
| June 30, 2015 | December 31, 2014 |  | June 30, 2015 | December 31, 2014
Equity swaps, options, and futures | $ | 4,591 |  | $ | 5,983 |  |  | $ | 165 |  | $ | 141 |
Foreign currency options | — |  | 400 |  |  | — |  | — |
Total | $ | 4,591 |  | $ | 6,383 |  |  | $ | 165 |  | $ | 141 |
| Notional Amount |  | Fair Value
| June 30, 2015 | December 31, 2014 |  | June 30, 2015 | December 31, 2014
Customized swaps | $ | 6,493 |  | $ | 7,041 |  |  | $ | 116 |  | $ | 124 |
Equity swaps, options, and futures | 1,719 |  | 3,761 |  |  | 10 |  | 39 |
Interest rate swaps and futures | 3,520 |  | 3,640 |  |  | 8 |  | 11 |
Total | $ | 11,732 |  | $ | 14,442 |  |  | $ | 134 |  | $ | 174 |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] |
| Net Derivatives |  | Asset Derivatives |  | Liability Derivatives
| Notional Amount |  | Fair Value |  | Fair Value |  | Fair Value
Hedge Designation/ Derivative Type | Jun. 30, 2015 | Dec. 31, 2014 |  | Jun. 30, 2015 | Dec. 31, 2014 |  | Jun. 30, 2015 | Dec. 31, 2014 |  | Jun. 30, 2015 | Dec. 31, 2014
Cash flow hedges |  |  |  |  |  |  |  |  |  |  |
Interest rate swaps | $ | 3,995 |  | $ | 3,999 |  |  | $ | 27 |  | $ | 44 |  |  | $ | 46 |  | $ | 52 |  |  | $ | (19 | ) | $ | (8 | )
Foreign currency swaps | 143 |  | 143 |  |  | (20 | ) | (19 | ) |  | 4 |  | 3 |  |  | (24 | ) | (22 | )
Total cash flow hedges | 4,138 |  | 4,142 |  |  | 7 |  | 25 |  |  | 50 |  | 55 |  |  | (43 | ) | (30 | )
Fair value hedges |  |  |  |  |  |  |  |  |  |  |
Interest rate swaps | 49 |  | 32 |  |  | — |  | — |  |  | — |  | — |  |  | — |  | — |
Total fair value hedges | 49 |  | 32 |  |  | — |  | — |  |  | — |  | — |  |  | — |  | — |
Non-qualifying strategies |  |  |  |  |  |  |  |  |  |  |
Interest rate contracts |  |  |  |  |  |  |  |  |  |  |
Interest rate swaps and futures | 14,958 |  | 15,254 |  |  | (474 | ) | (512 | ) |  | 428 |  | 536 |  |  | (902 | ) | (1,048 | )
Foreign exchange contracts |  |  |  |  |  |  |  |  |  |  |
Foreign currency swaps and forwards | 186 |  | 177 |  |  | 8 |  | 1 |  |  | 8 |  | 3 |  |  | — |  | (2 | )
Fixed payout annuity hedge | 1,319 |  | 1,319 |  |  | (458 | ) | (427 | ) |  | — |  | — |  |  | (458 | ) | (427 | )
Credit contracts |  |  |  |  |  |  |  |  |  |  |
Credit derivatives that purchase credit protection | 209 |  | 595 |  |  | 2 |  | (6 | ) |  | 4 |  | 4 |  |  | (2 | ) | (10 | )
Credit derivatives that assume credit risk [1] | 3,067 |  | 1,487 |  |  | 4 |  | 3 |  |  | 30 |  | 14 |  |  | (26 | ) | (11 | )
Credit derivatives in offsetting positions | 4,158 |  | 5,343 |  |  | (2 | ) | (3 | ) |  | 46 |  | 53 |  |  | (48 | ) | (56 | )
Equity contracts |  |  |  |  |  |  |  |  |  |  |
Equity index swaps and options | 129 |  | 635 |  |  | (1 | ) | 2 |  |  | 28 |  | 31 |  |  | (29 | ) | (29 | )
Commodity contracts |  |  |  |  |  |  |  |  |  |  |
Commodity options | 637 |  | — |  |  | 3 |  | — |  |  | 3 |  | — |  |  | — |  | — |
Variable annuity hedge program |  |  |  |  |  |  |  |  |  |  |
GMWB product derivatives [2] | 16,361 |  | 17,908 |  |  | (112 | ) | (139 | ) |  | — |  | — |  |  | (112 | ) | (139 | )
GMWB reinsurance contracts | 3,366 |  | 3,659 |  |  | 50 |  | 56 |  |  | 50 |  | 56 |  |  | — |  | — |
GMWB hedging instruments | 11,732 |  | 14,442 |  |  | 134 |  | 174 |  |  | 246 |  | 289 |  |  | (112 | ) | (115 | )
Macro hedge program | 4,591 |  | 6,383 |  |  | 165 |  | 141 |  |  | 200 |  | 180 |  |  | (35 | ) | (39 | )
Other |  |  |  |  |  |  |  |  |  |  |
Contingent capital facility put option | 500 |  | 500 |  |  | 9 |  | 12 |  |  | 9 |  | 12 |  |  | — |  | — |
Modified coinsurance reinsurance contracts | 921 |  | 974 |  |  | 60 |  | 34 |  |  | 60 |  | 34 |  |  | — |  | — |
Total non-qualifying strategies | 62,134 |  | 68,676 |  |  | (612 | ) | (664 | ) |  | 1,112 |  | 1,212 |  |  | (1,724 | ) | (1,876 | )
Total cash flow hedges, fair value hedges, and non-qualifying strategies | $ | 66,321 |  | $ | 72,850 |  |  | $ | (605 | ) | $ | (639 | ) |  | $ | 1,162 |  | $ | 1,267 |  |  | $ | (1,767 | ) | $ | (1,906 | )
Balance Sheet Location |  |  |  |  |  |  |  |  |  |  |
Fixed maturities, available-for-sale | $ | 448 |  | $ | 454 |  |  | $ | (3 | ) | $ | 2 |  |  | $ | — |  | $ | 2 |  |  | $ | (3 | ) | $ | — |
Other investments | 25,401 |  | 23,014 |  |  | 308 |  | 364 |  |  | 590 |  | 624 |  |  | (282 | ) | (260 | )
Other liabilities | 19,774 |  | 26,791 |  |  | (882 | ) | (930 | ) |  | 462 |  | 551 |  |  | (1,344 | ) | (1,481 | )
Reinsurance recoverables | 4,287 |  | 4,633 |  |  | 110 |  | 90 |  |  | 110 |  | 90 |  |  | — |  | — |
Other policyholder funds and benefits payable | 16,411 |  | 17,958 |  |  | (138 | ) | (165 | ) |  | — |  | — |  |  | (138 | ) | (165 | )
Total derivatives | $ | 66,321 |  | $ | 72,850 |  |  | $ | (605 | ) | $ | (639 | ) |  | $ | 1,162 |  | $ | 1,267 |  |  | $ | (1,767 | ) | $ | (1,906 | )
[1] | The derivative instruments related to this strategy are held for other investment purposes.
[2] | These derivatives are embedded within liabilities and are not held for risk management purposes.
Offsetting Assets [Table Text Block] |
| (i) |  | (ii) |  | (iii) = (i) - (ii) | (iv) |  | (v) = (iii) - (iv)
|  |  |  |  | Net Amounts Presented in the Statement of Financial Position |  | Collateral Disallowed for Offset in the Statement of Financial Position |  |
| Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Statement of Financial Position |  | Derivative Assets [1] |  | Accrued Interest and Cash Collateral Received [2] |  | Financial Collateral Received [4] |  | Net Amount
Description |  |  |  |  |  |  |  |  |  |  |
Other investments | $ | 1,175 |  |  | $ | 969 |  |  | $ | 364 |  |  | $ | (158 | ) |  | $ | 109 |  |  | $ | 97 |
The following tables present the gross fair value amounts, the amounts offset, and net position of derivative instruments eligible for offset in the Company's Condensed Consolidated Balance Sheets. Amounts offset include fair value amounts, income accruals and related cash collateral receivables and payables associated with derivative instruments that are traded under a common master netting agreement, as described in the preceding discussion. Also included in the tables are financial collateral receivables and payables, which are contractually permitted to be offset upon an event of default, although are disallowed for offsetting under U.S. GAAP. As of June 30, 2015
| (i) |  | (ii) |  | (iii) = (i) - (ii) | (iv) |  | (v) = (iii) - (iv)
|  |  |  |  | Net Amounts Presented in the Statement of Financial Position |  | Collateral Disallowed for Offset in the Statement of Financial Position |  |
| Gross Amounts of Recognized Assets |  | Gross Amounts Offset in the Statement of Financial Position |  | Derivative Assets [1] |  | Accrued Interest and Cash Collateral Received [2] |  | Financial Collateral Received [4] |  | Net Amount
Description |  |  |  |  |  |  |  |  |  |  |
Other investments | $ | 1,052 |  |  | $ | 868 |  |  | $ | 308 |  |  | $ | (124 | ) |  | $ | 86 |  |  | $ | 98 |
Offsetting Liabilities [Table Text Block] |
| Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Statement of Financial Position |  | Derivative Liabilities [3] |  | Accrued Interest and Cash Collateral Pledged [3] |  | Financial Collateral Pledged [4] |  | Net Amount
Description |  |  |  |  |  |  |  |  |  |  |
Other liabilities | $ | (1,741 | ) |  | $ | (799 | ) |  | $ | (927 | ) |  | $ | (15 | ) |  | $ | (1,079 | ) |  | $ | 137 |
[1] | Included in other invested assets in the Company's Condensed Consolidated Balance Sheets.
[2] | Included in other assets in the Company's Condensed Consolidated Balance Sheets and is limited to the net derivative receivable associated with each counterparty.
[3] | Included in other liabilities in the Company's Condensed Consolidated Balance Sheets and is limited to the net derivative payable associated with each counterparty. Not included in this amount are embedded derivatives associated with consumer notes of $(3) as of June 30, 2015 and December 31, 2014, which were not eligible for offset in the Company's Condensed Consolidated Balance Sheets.
[4] | Excludes collateral associated with exchange-traded derivative instruments.
| Gross Amounts of Recognized Liabilities |  | Gross Amounts Offset in the Statement of Financial Position |  | Derivative Liabilities [3] |  | Accrued Interest and Cash Collateral Pledged [3] |  | Financial Collateral Pledged [4] |  | Net Amount
Description |  |  |  |  |  |  |  |  |  |  |
Other liabilities | $ | (1,626 | ) |  | $ | (677 | ) |  | $ | (879 | ) |  | $ | (70 | ) |  | $ | (1,159 | ) |  | $ | 210 |
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] | Derivatives in Cash Flow Hedging Relationships
| Gain (Loss) Recognized in OCI on Derivative (Effective Portion) |  | Net Realized Capital Gains(Losses) Recognized in Income on Derivative (Ineffective Portion)
| Three Months Ended June 30, | Six Months Ended June 30, |  | Three Months Ended June 30, | Six Months Ended June 30,
| 2015 | 2014 | 2015 | 2014 |  | 2015 | 2014 | 2015 | 2014
Interest rate swaps | $ | (71 | ) | $ | 57 |  | $ | (15 | ) | $ | 101 |  |  | $ | — |  | $ | — |  | $ | — |  | $ | (1 | )
Foreign currency swaps | 6 |  | (2 | ) | (1 | ) | (3 | ) |  | — |  | — |  | — |  | — |
Total | $ | (65 | ) | $ | 55 |  | $ | (16 | ) | $ | 98 |  |  | $ | — |  | $ | — |  | $ | — |  | $ | (1 | )
|  | Gain or (Loss) Reclassified from AOCI into Income (Effective Portion)
|  | Three Months Ended June 30, |  | Six Months Ended June 30,
| Location | 2015 | 2014 |  | 2015 | 2014
Interest rate swaps | Net realized capital gain (loss) | $ | 2 |  | $ | 1 |  |  | $ | 3 |  | $ | 2 |
Interest rate swaps | Net investment income | 16 |  | 22 |  |  | 32 |  | 45 |
Foreign currency swaps | Net realized capital gain (loss) | 3 |  | — |  |  | (7 | ) | — |
Total |  | $ | 21 |  | $ | 23 |  |  | $ | 28 |  | $ | 47 |
Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] | rivatives in Fair Value Hedging Relationships
|  | Gain or (Loss) Recognized in Income [1]
|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2015 |  | 2014 |  | 2015 |  | 2014
| Location | Derivative | Hedge Item |  | Derivative | Hedge Item |  | Derivative | Hedge Item |  | Derivative | Hedge Item
Interest rate swaps | Net realized capital gain (loss) | $ | — |  | $ | — |  |  | $ | (1 | ) | $ | — |  |  | $ | — |  | $ | — |  |  | $ | (2 | ) | $ | — |
[1] | The amounts presented do not include the periodic net coupon settlements of the derivative or the coupon income (expense) related to the hedged item. The net of the amounts presented represents the ineffective portion of the hedge.
Gain or Loss Recognized with in Net Realized Capital Gains Losses on Non Qualifying Strategies [Table Text Block] | Derivatives Used in Non-Qualifying Strategies Gain or (Loss) Recognized within Net Realized Capital Gains and Losses
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2015 | 2014 |  | 2015 | 2014
Interest rate contracts |  |  |  |  |
Interest rate swaps and forwards | $ | 7 |  | $ | (89 | ) |  | $ | (5 | ) | $ | (145 | )
Foreign exchange contracts |  |  |  |  |
Foreign currency swaps and forwards | 1 |  | (5 | ) |  | 8 |  | (4 | )
Fixed payout annuity hedge [1] | (17 | ) | 13 |  |  | (31 | ) | 28 |
Credit contracts |  |  |  |  |
Credit derivatives that purchase credit protection | — |  | (6 | ) |  | (2 | ) | (10 | )
Credit derivatives that assume credit risk | (11 | ) | 20 |  |  | (2 | ) | 19 |
Equity contracts |  |  |  |  |
Equity index swaps and options | 6 |  | (1 | ) |  | 3 |  | (1 | )
Commodity contracts |  |  |  |  |
Commodity options | (5 | ) | — |  |  | (10 | ) | — |
Variable annuity hedge program |  |  |  |  |
GMWB product derivatives | 78 |  | 55 |  |  | 59 |  | 91 |
GMWB reinsurance contracts | (16 | ) | (7 | ) |  | (9 | ) | (11 | )
GMWB hedging instruments | (66 | ) | (54 | ) |  | (53 | ) | (71 | )
Macro hedge program | (23 | ) | (15 | ) |  | (27 | ) | (25 | )
Other |  |  |  |  |
Contingent capital facility put option | (2 | ) | (2 | ) |  | (3 | ) | (3 | )
Modified coinsurance reinsurance contracts | 37 |  | (16 | ) |  | 26 |  | (35 | )
Total [2] | $ | (11 | ) | $ | (107 | ) |  | $ | (46 | ) | $ | (167 | )
[1] | Not included in this amount is the associated liability adjustment for changes in foreign exchange spot rates through realized capital gains of $16 and $(18) for the three months ended June 30, 2015 and 2014, respectively, and $16 and $(46) for the six months ended June 30, 2015 and 2014, respectively.
[2] | Excludes investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 4 - Fair Value Measurements.
Disclosure of Credit Derivatives [Table Text Block] | As of June 30, 2015
|  |  |  | Underlying Referenced Credit Obligation(s) [1] |  |
Credit Derivative type by derivative risk exposure | Notional Amount [2] | Fair Value | Weighted Average Years to Maturity | Type | Average Credit Rating | Offsetting Notional Amount [3] | Offsetting Fair Value [3]
Single name credit default swaps |  |  |  |  |  |  |
Investment grade risk exposure | $ | 242 |  | $ | 3 |  | 2 years | Corporate Credit/ Foreign Gov. | BBB+ | $ | 217 |  | $ | (4 | )
Below investment grade risk exposure | 29 |  | — |  | 2 years | Corporate Credit | BB | 29 |  | (1 | )
Basket credit default swaps [4] |  |  |  |  |  |  |
Investment grade risk exposure | 3,232 |  | 45 |  | 4 years | Corporate Credit | BBB+ | 1,414 |  | (20 | )
Below investment grade risk exposure | 58 |  | 4 |  | 5 years | Corporate Credit | B+ | — |  | — |
Investment grade risk exposure | 1,081 |  | (24 | ) | 7 years | CMBS Credit | AAA- | 265 |  | 2 |
Below investment grade risk exposure | 154 |  | (22 | ) | 2 years | CMBS Credit | CCC+ | 154 |  | 22 |
Embedded credit derivatives |  |  |  |  |  |  |
Investment grade risk exposure | 350 |  | 346 |  | 2 years | Corporate Credit | A+ | — |  | — |
Total [5] | $ | 5,146 |  | $ | 352 |  |  |  |  | $ | 2,079 |  | $ | (1 | )
As of December 31, 2014
|  |  |  | Underlying Referenced Credit Obligation(s) [1] |  |
Credit Derivative Type by Derivative Risk Exposure | Notional Amount [2] | Fair Value | Weighted Average Years to Maturity | Type | Average Credit Rating | Offsetting Notional Amount [3] | Offsetting Fair Value [3]
Single name credit default swaps |  |  |  |  |  |  |
Investment grade risk exposure | $ | 320 |  | $ | 5 |  | 2 years | Corporate Credit/ Foreign Gov. | BBB+ | $ | 247 |  | $ | (5 | )
Below investment grade risk exposure | 29 |  | — |  | 2 years | Corporate Credit | BB | 29 |  | (1 | )
Basket credit default swaps [4] |  |  |  |  |  |  |
Investment grade risk exposure | 2,546 |  | 33 |  | 3 years | Corporate Credit | BBB | 1,973 |  | (25 | )
Below investment grade risk exposure | 38 |  | (1 | ) | 12 years | Corporate Credit | D | — |  | — |
Investment grade risk exposure | 722 |  | (12 | ) | 6 years | CMBS Credit | AA+ | 269 |  | 3 |
Below investment grade risk exposure | 154 |  | (22 | ) | 2 years | CMBS Credit | CCC+ | 154 |  | 23 |
Embedded credit derivatives |  |  |  |  |  |  |
Investment grade risk exposure | 350 |  | 342 |  | 2 years | Corporate Credit | A | — |  | — |
Total [5] | $ | 4,159 |  | $ | 345 |  |  |  |  | $ | 2,672 |  | $ | (5 | )
[1] | The average credit ratings are based on availability and the midpoint of the applicable ratings among Moody’s, S&P, Fitch, and Morningstar. If no rating is available from a rating agency, then an internally developed rating is used.
[2] | Notional amount is equal to the maximum potential future loss amount. These derivatives are governed by agreements, clearing house rules and applicable law which include collateral posting requirements. There is no additional specific collateral related to these contracts or recourse provisions included in the contracts to offset losses.
[3] | The Company has entered into offsetting credit default swaps to terminate certain existing credit default swaps, thereby offsetting the future changes in value of, or losses paid related to, the original swap.
[4] | Includes $4.5 billion and $3.5 billion as of June 30, 2015 and December 31, 2014, respectively, of standard market indices of diversified portfolios of corporate and CMBS issuers referenced through credit default swaps. These swaps are subsequently valued based upon the observable standard market index.
[5] | Excludes investments that contain an embedded credit derivative for which the Company has elected the fair value option. For further discussion, see the Fair Value Option section in Note 4 - Fair Value Measurements.
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] | Mortgage Loans Mortgage Loan Valuation Allowances The Company’s security monitoring process reviews mortgage loans on a quarterly basis to identify potential credit losses. Commercial mortgage loans are considered to be impaired when management estimates that, based upon current information and events, it is probable that the Company will be unable to collect amounts due according to the contractual terms of the loan agreement. Criteria used to determine if an impairment exists include, but are not limited to: current and projected macroeconomic factors, such as unemployment rates, and property-specific factors such as rental rates, occupancy levels, LTV ratios and debt service coverage ratios (“DSCR”). In addition, the Company considers historic, current and projected delinquency rates and property values. These assumptions require the use of significant management judgment and include the probability and timing of borrower default and loss severity estimates. In addition, projections of expected future cash flows may change based upon new information regarding the performance of the borrower and/or underlying collateral such as changes in the projections of the underlying property value estimates. For mortgage loans that are deemed impaired, a valuation allowance is established for the difference between the carrying amount and the Company’s share of either (a) the present value of the expected future cash flows discounted at the loan’s effective interest rate, (b) the loan’s observable market price or, most frequently, (c) the fair value of the collateral. A valuation allowance has been established for either individual loans or as a projected loss contingency for loans with an LTV ratio of 90% or greater and consideration of other credit quality factors, including DSCR. Changes in valuation allowances are recorded in net realized capital gains and losses. Interest income on impaired loans is accrued to the extent it is deemed collectible and the loans continue to perform under the original or restructured terms. Interest income ceases to accrue for loans when it is probable that the Company will not receive interest and principal payments according to the contractual terms of the loan agreement. Loans may resume accrual status when it is determined that sufficient collateral exists to satisfy the full amount of the loan and interest payments, as well as when it is probable cash will be received in the foreseeable future. Interest income on defaulted loans is recognized when received.
| June 30, 2015 |  | December 31, 2014
| Amortized Cost [1] | Valuation Allowance | Carrying Value |  | Amortized Cost [1] | Valuation Allowance | Carrying Value
Total commercial mortgage loans | $ | 5,714 |  | $ | (21 | ) | $ | 5,693 |  |  | $ | 5,574 |  | $ | (18 | ) | $ | 5,556 |
[1] | Amortized cost represents carrying value prior to valuation allowances, if any.
As of June 30, 2015 and December 31, 2014, the carrying value of mortgage loans associated with the valuation allowance was $108 and $140, respectively. There were no mortgage loans held-for-sale as of June 30, 2015 or December 31, 2014. As of June 30, 2015, loans within the Company’s mortgage loan portfolio that have had extensions or restructurings other than what is allowable under the original terms of the contract are immaterial. The following tables present the carrying value of the Company’s mortgage loans by region and property type.
Mortgage Loans by Region
| June 30, 2015 |  | December 31, 2014
| Carrying Value | Percent of Total |  | Carrying Value | Percent of Total
East North Central | $ | 242 |  | 4.3 | % |  | $ | 211 |  | 3.8 | %
Middle Atlantic | 439 |  | 7.7 | % |  | 468 |  | 8.4 | %
Mountain | 88 |  | 1.5 | % |  | 88 |  | 1.6 | %
New England | 407 |  | 7.1 | % |  | 381 |  | 6.9 | %
Pacific | 1,640 |  | 28.9 | % |  | 1,607 |  | 29.0 | %
South Atlantic | 1,159 |  | 20.4 | % |  | 1,019 |  | 18.3 | %
West North Central | 30 |  | 0.5 | % |  | 44 |  | 0.8 | %
West South Central | 319 |  | 5.6 | % |  | 302 |  | 5.4 | %
Other [1] | 1,369 |  | 24.0 | % |  | 1,436 |  | 25.8 | %
Total mortgage loans | $ | 5,693 |  | 100.0 | % |  | $ | 5,556 |  | 100.0 | %
[1] | Primarily represents loans collateralized by multiple properties in various regions.
The following table presents the activity within the Company’s valuation allowance for mortgage loans. These loans have been evaluated both individually and collectively for impairment. Loans evaluated collectively for impairment are immaterial.
| 2015 | 2014
Balance, as of January 1 | $ | (18 | ) | $ | (67 | )
(Additions)/Reversals | (3 | ) | (3 | )
Deductions | — |  | 51 |
Balance, as of June 30 | $ | (21 | ) | $ | (19 | )
Mortgage Loans by Property Type
| June 30, 2015 |  | December 31, 2014
| Carrying Value | Percent of Total |  | Carrying Value | Percent of Total
Commercial |  |  |  |  |
Agricultural | $ | 46 |  | 0.8 | % |  | $ | 46 |  | 0.8 | %
Industrial | 1,535 |  | 27.0 | % |  | 1,476 |  | 26.6 | %
Lodging | 26 |  | 0.5 | % |  | 26 |  | 0.5 | %
Multifamily | 1,308 |  | 23.0 | % |  | 1,190 |  | 21.4 | %
Office | 1,563 |  | 27.4 | % |  | 1,517 |  | 27.3 | %
Retail | 1,061 |  | 18.6 | % |  | 1,147 |  | 20.6 | %
Other | 154 |  | 2.7 | % |  | 154 |  | 2.8 | %
Total mortgage loans | $ | 5,693 |  | 100.0 | % |  | $ | 5,556 |  | 100.0 | %
The following table presents the carrying value of the Company’s commercial mortgage loans by LTV and DSCR.
Commercial Mortgage Loans Credit Quality
| June 30, 2015 |  | December 31, 2014
Loan-to-value | Carrying Value | Avg. Debt-Service Coverage Ratio |  | Carrying Value | Avg. Debt-Service Coverage Ratio
Greater than 80% | $ | 26 |  | 1.11x |  | $ | 53 |  | 1.07x
65% - 80% | 927 |  | 1.77x |  | 789 |  | 1.75x
Less than 65% | 4,740 |  | 2.74x |  | 4,714 |  | 2.66x
Total commercial mortgage loans | $ | 5,693 |  | 2.57x |  | $ | 5,556 |  | 2.51x

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of credit derivatives which includes information by sellers of credit derivatives, about each credit derivative, or each group of similar credit derivatives, including (a) the nature of the credit derivative - its term, how it arose, the events or circumstances that would require the seller to perform under the credit derivative, and the current status of the payment/performance risk of the credit derivative; (b) the maximum potential amount of future payments (undiscounted) the seller could be required to make under the credit derivative; (c) the current fair value of the credit derivative; and (d) the nature of any recourse provisions under the credit derivative, and any assets held either as collateral or by third parties. A credit derivative is a derivative instrument (1) in which one or more of its underlyings are related to the credit risk of a specified entity (or a group of entities) or an index based on the credit risk of a group of entities and (2) that exposes the seller to potential loss from credit-risk-related events specified in the contract. Examples of credit derivatives within the scope of this paragraph include, but are not limited to, credit default swaps, credit spread options, and credit index products; also includes a hybrid instrument that has an embedded credit derivative (for example, but not limited to, a credit-linked note). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Credit Derivative -URI http://asc.fasb.org/extlink&oid=6854095 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4L -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708777-113959 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4K -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708775-113959 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4J -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5708773-113959 + Details
Name: | us-gaap_DisclosureOfCreditDerivativesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments. + References No definition available. + Details
Name: | us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312 + Details
Name: | us-gaap_OffsettingAssetsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 20 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312 + Details
Name: | us-gaap_OffsettingLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of other than temporary impairment (OTTI) related to credit losses recognized in earnings including: (a) the beginning balance of the amount related to credit losses on debt securities held by the investor at the beginning of the period for which a portion of an OTTI was recognized in other comprehensive income; (b) additions for the amount related to the credit loss for which an OTTI was not previously recognized; (c) reductions for securities sold during the period (realized); (d) reductions for securities for which the amount previously recognized in other comprehensive income was recognized in earnings because the investor intends to sell the security or more likely than not will be required to sell the security before recovery of its amortized cost basis; (e) additional increases to the amount related to the credit loss for which an OTTI was previously recognized when the investor does not intend to sell the security and it is not more likely than not that the investor will be required to sell the security before recovery of its amortized cost basis; (f) reductions for increases in cash flows expected to be collected that are recognized over the remaining life of the security; and (g) the ending balance of the amount related to credit losses on debt securities held by the entity at the end of the period for which a portion of an OTTI was recognized in other comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27340-111563 + Details
Name: | us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of realized gains and losses on investments reported in the statement of income. + References No definition available. + Details
Name: | us-gaap_RealizedGainLossOnInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3,4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for cash flow hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfCashFlowHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5618551-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41641-113959 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624163-113959 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41678-113959 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41638-113959 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1B -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5580258-113959 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1A -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579245-113959 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 25 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5579240-113959 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=56946850&loc=d3e41620-113959 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(n)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=56946850&loc=SL5624171-113959 + Details
Name: | us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition For all investments in an unrealized loss position, including those for which other-than-temporary impairments have not been recognized in earnings (including investments for which a portion of an other-than-temporary impairment has been recognized in other comprehensive income), a tabular disclosure of the aggregate related fair value of investments with unrealized losses and the aggregate amount of unrealized losses (that is, the amount by which amortized cost basis exceeds fair value). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=27724398&loc=d3e27290-111563 + Details
Name: | us-gaap_ScheduleOfUnrealizedLossOnInvestmentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5747-111685 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=52262685&loc=SL6228884-111685 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5728-111685 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Variable Interest Entity -URI http://asc.fasb.org/extlink&oid=6528138 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 5A -URI http://asc.fasb.org/extlink&oid=52262685&loc=SL6759159-111685 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5710-111685 + Details
Name: | us-gaap_ScheduleOfVariableInterestEntitiesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration